ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 45 filers reported holding ATYR PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $927,668 | -27.6% | 586,997 | -1.1% | 0.00% | – |
| Q2 2023 | $1,281,903 | +5.4% | 593,474 | +2.5% | 0.00% | – |
| Q1 2023 | $1,215,694 | +229276.2% | 578,902 | +139.0% | 0.00% | – |
| Q4 2022 | $530 | -99.9% | 242,239 | +1.1% | 0.00% | – |
| Q3 2022 | $718,000 | +6.4% | 239,496 | +0.3% | 0.00% | – |
| Q2 2022 | $675,000 | -46.1% | 238,809 | +1.9% | 0.00% | – |
| Q1 2022 | $1,253,000 | -27.5% | 234,322 | +1.2% | 0.00% | – |
| Q4 2021 | $1,729,000 | +46.3% | 231,499 | +77.7% | 0.00% | – |
| Q3 2021 | $1,182,000 | +120.9% | 130,282 | +18.7% | 0.00% | – |
| Q2 2021 | $535,000 | +99.6% | 109,761 | +82.2% | 0.00% | – |
| Q1 2021 | $268,000 | +42.6% | 60,248 | +24.0% | 0.00% | – |
| Q4 2020 | $188,000 | +27.0% | 48,598 | +5.4% | 0.00% | – |
| Q3 2020 | $148,000 | -27.5% | 46,130 | 0.0% | 0.00% | – |
| Q2 2020 | $204,000 | +466.7% | 46,130 | +253.8% | 0.00% | – |
| Q1 2020 | $36,000 | -66.7% | 13,040 | -50.0% | 0.00% | – |
| Q4 2019 | $108,000 | +140.0% | 26,080 | +100.0% | 0.00% | – |
| Q3 2019 | $45,000 | – | 13,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |